BioClinica, Inc., formerly Bio-Imaging Technologies, Inc., founded in 1990, is a Pennsylvania-based company that supports pharmaceutical and medical device innovation.BioClinica’s initial service was medical imaging for clinical trials. It is used to capture, collect, control quality, provide blinded reading services to the final delivery to the sponsor company and to the FDA or EMEA if required for medical images in a wide range of imaging modalities. Wikipedia.
News Article | December 15, 2016
The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations are the key drivers for the growth of the clinical trial imaging market. Developing markets in Asia such as Japan, China, and India are lucrative markets for clinical trial imaging. Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian clinical trial imaging market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region. Complete report on global clinical trial imaging market spread across 123 pages, profiling 10 companies and supported with 77 tables and 32 figures is now available at http://www.reportsnreports.com/reports/785426-clinical-trial-imaging-market-by-product-services-software-modality-ct-mri-pet-ultrasound-echocardiography-x-ray-end-user-pharmaceutical-companies-biotechnology-companies-cros-medical-device-manufac-st-to-2021.html . On the basis of product and service, the clinical trial imaging market is segmented into software and services. Services segment is classified into operational imaging services, reader services, systems & technology, and design consulting. The service segment is expected to account for the largest share of the clinical trial imaging market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers. On the basis of modality, the clinical trial imaging market is broadly classified into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities. In 2016, the CT segment is expected to account for the largest share of the global clinical trial imaging market. The large share of this segment is attributed to the high advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body. The key players in the global clinical trial imaging market are BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), BioTelemetric, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.). Order a copy of Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021 research report at http://www.reportsnreports.com/purchase.aspx?name=785426 . On the basis of end user, the clinical trial imaging market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users. In 2016, Pharmaceutical companies form the largest end-user segment of the clinical trial imaging market. Increased R&D budgets of pharmaceutical companies are the primary growth driver for this end-user segment. Collaboration, Partnership, and Agreement was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs. Inquiry Before Buying on this Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=785426 . RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. For more information, please visit http://www.reportsnreports.com
News Article | November 17, 2016
The report covers forecast and analysis for the clinical trial imaging market on a global and regional level. According to the report, the global clinical trial imaging market was valued at approximately USD 731.9 million in 2015 and is expected to reach approximately USD 1,052.9 million by 2021, growing at a CAGR of around 6.30% between 2016 and 2021. The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the clinical trial imaging market on a global level. In order to give the users of this report a comprehensive view on the clinical trial imaging market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the clinical trial imaging market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness. The clinical trial imaging market is segmented on the basis of service and software. Service accounted for a large chunk of the global clinical trial imaging market in 2015. Software is another leading segment and it accounted for 35.2% share of total market in 2015. This growth is mainly attributed to high investment in R&D activities coupled with government support. Based on technology, the global clinical trial imaging market is segmented as echo, PET, MRI, X-Ray, CT, and ultrasound and others. The CT segment dominated the market with over 31.0% share of the total market in 2015. MRI, PET and ultrasound are also accounted for significant share owing to the increasing disabled and aging populations who are commonly diagnosed with different disease and other complications. Some of the key end-users of the clinical trial imaging market include biotech companies, pharmaceutical, research centers, hospitals and others. Among all end-users, pharmaceutical was the leading segment and it accounted for over 45.0% share of the total revenue generated in 2015. Biotech companies another key outlet of the market and expected to exhibit significant growth within the forecast period. This growth is mainly due to rising development in bio-pharmaceutical industries. The study provides a decisive view on the clinical trial imaging market by segmenting the market based on product, technology, end user and region. Software and service are segments of product, where, Software is designed for clinical trial imaging. Services including operational imaging services, reader service, system and technology, design consulting. Various technologies in clinical imaging include echo, PET, MRI, x ray, CT, and ultrasound among others. MRI, CT, X-ray, ultrasound are the technologies having highest share in clinical trial imaging market. Different end users in this market are biotech companies, pharmaceuticals, research center, hospitals, diagnosis centers and others. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil. The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. The key players of clinical trials imaging market include Cardiovascular Imaging Technologies, VirtualScopic, Biomedical Systems, BioClinica, Intrinsic Imaging LLC, Prism Clinical Imaging, PAREXEL International Corporation, and ICON among others. This report segments the global clinical trial imaging market as follows:
News Article | December 13, 2016
The report "Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021" The global market is projected to reach USD 1069.7 Million by 2021 from USD 773.4 Million in 2016, at a CAGR of 6.7% from 2016 to 2021. The report provides a granular understanding of the clinical trials imaging market. Browse 77 market data Tables and 32 Figures spread through 123 Pages and in-depth TOC on "Clinical Trial Imaging Market" Early buyers will receive 10% customization on this report. The report provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue. Major factors fueling market growth are the increasing number of contract research organizations, growth in the pharmaceutical and biotechnology industries, and increase in R&D spending are the key drivers for the growth of the clinical trial imaging market. On the other hand, the high implementation cost of imaging systems is restraining the growth of this market. The clinical trial imaging market, on the basis of product and service, is segmented into service and software. Of these, the service segment is expected to account for the largest share as well as the highest CAGR of the clinical trial imaging market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers. On the basis of type, the services segment is further classified into operational imaging services, reader services, systems and technology support services, and design consulting services. The operational imaging services segment is expected to account for the largest share of the global clinical trial imaging services market in 2016 as it constitutes the core services offered by imaging CROs for different imaging modalities. Furthermore, on the basis of modality, the clinical trial imaging market is broadly classified into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities. In 2016, the CT segment is expected to account for the largest share of the global clinical trial imaging market. The large share of this segment is attributed to the high advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body. Similarly, in 2016, the PET segment is expected to grow at a highest CAGR in the clinical trial imaging market. The highest growth of this segment is primarily attributed to the high advantages of PET in providing information about the function and metabolism of the body's organs. On the basis of end user, the clinical trial imaging market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users. Pharmaceutical companies are expected to account for the largest share of the global clinical trial imaging end user market in 2016. Increased R&D budgets of pharmaceutical companies is the primary growth driver for this end-user segment. However, medical device manufacturers are growing at a highest CAGR in the forecast period. Increased R&D spending by medical device manufacturers and the growing medical devices market are the primary growth drivers of the medical device manufacturer's end user segment. Geographically, the clinical trial imaging market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to command the largest share of the global clinical trial imaging market in 2016. This market is primarily driven by large R&D spending, growing number of pharmaceutical & biotechnology companies, and increasing number of CROs. Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian clinical trial imaging market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region. The key players in the global clinical trial imaging market are BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), BioTelemetric, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.). MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
News Article | February 27, 2017
The report "(CTMS) Clinical Trial Management System Market Size By Component (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode (Web, Cloud, On Premise), By End Use (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Poland, Russia, China, India, Japan, South Korea, Taiwan, Brazil, Mexico, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 - 2024" by Global Market Insights, Inc. says CTMS Market size is poised to surpass USD 2 billion by 2024. Growing prevalence of chronic diseases, surge in clinical trials outsourcing, rising R&D cost and favorable government initiatives will drive global clinical trial management system market size. Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1155 Improvements in regulatory framework for drug approvals and patent laws along with rapid economic development in emerging countries of India and China will expand clinical trial management system market size. Quality trials at reduced cost continues to remain unique proposition for regional industry growth. Stringent regulatory guidelines to ensure drug safety & efficacy, extended approval time, difficulties in recruitment for trials and increasing number of clinical trial failures in phase II and phase III should hinder clinical trial management system market growth. Hardware component was valued at over USD 90 million in 2015, and is estimated to expand at 13.1% CAGR from 2016 to 2024. Pharmaceutical companies are outsourcing their requirement to specialized firms in other regions. This has resulted in increase in sales of hardware components used for clinical trial management system. Enterprise based accounted for over 70% of clinical trial management system market share in 2015 and is projected to grow at 13.8% CAGR from 2016 to 2024. It provides dedicated services with special in house capabilities for clinical trials management. Cloud delivery mode is projected to witness robust growth of over 15% from 2016 to 2024 and expected to reach over USD 350 million by 2024. In terms of revenue share, Web and On Premise together account for over 85% clinical trial management market share in 2015, growing at over 14% and 11.5% from 2016 to 2024 respectively. Pharmaceutical and biopharmaceutical companies are estimated to surpass USD 1.4 billion by 2024. As these organizations are continuously striving to develop potent novel drugs and therapeutics to use against diseases and disorders. China clinical trial management system market size is anticipated to generate over USD 270 million in terms of value by 2024. Increasing government policies to setup a research center and growing R&D investments in life sciences, pharmaceutical, and clinical research industries, along with combination of HIS with CTMS, additionally the increased clinical research outsourcing and increasing prevalence of diseases. Browse key industry insights spread across 105 pages with 92 data tables & 6 figures & charts from this 2017 report Clinical Trial Management System Market in detail along with the table of contents at: U.S. clinical trial management system market share was over 70% of regional industry revenue in 2015. The factors driving business growth include favorable regulatory environment, effective ADR monitoring and evaluation policies and improved government funding. Germany clinical trial management system market size held more than 15% industry share in 2015 and anticipated to exceed USD 180 million by 2024. Favorable clinical trial regulations should boost the industry growth over the forecast period. India clinical trial management system market size was around USD 50 million in 2015, expected to witness robust growth of more than 22% from 2016 to 2024 due to growing preference for conducting clinical trials associated with its low cost and good quality of trials. Latin America clinical trial management system market size is expected to surpass USD 110 million by 2024, owing to favorable government regulations and increased adoption of new medical technologies in the areas of clinical chemistry and biomedical research. Global clinical trial management system industry is highly fragmented and competitive in nature. Some of the notable industry players include MedNet Solutions, Oracle Corporation, Bio-Optronics, BioClinica, Medidata solutions, PAREXEL International Corporation, Merge Healthcare, DATATRAK International, and VEEVA Systems. Other prominent participants include eClinForce, Forte Research Systems, and DSG. Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1155 Clinical trial management system market research report includes in-depth coverage of the industry with estimates & forecast in terms of value and volume in USD million from 2012 to 2024 , for the following segments: The above information is provided on a regional and country basis for the following: Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
News Article | February 21, 2017
Bioclinica®, a leading provider of technology-enabled clinical trial solutions, today announced the further expansion of its eHealth App xChange™, providing clinical researchers more choices in the types of applications they can leverage as part of Bioclinica’s extensive and growing eHealth platform. Applications that enable patient-centered clinical trials make up the fastest-growing App xChange category and include a variety of patient engagement tools. Additionally, partners bringing advanced analytics and machine learning capabilities aimed at reducing risks and improving process and workflow efficiencies are increasingly joining Bioclinica’s App xChange. Established in 2015 to spur clinical trial innovation, App xChange creates an environment for collaboration among technology providers, and allows sponsors to leverage the value of integration within Bioclinica’s secure, validated eHealth Cloud™. “Recognizing the shift in the bio-pharma industry to an increased number of stakeholders and differing priorities, we’ve expanded our partner approach to a wider array of technology providers that can help the industry drive transformational change,” says Bioclinica’s Vice President Technology Alliances, eHealth Solutions, Anne Zielinski. Currently 18 partners are in the eHealth App xChange, a complete listing of which can be viewed in Bioclinica’s dynamic eHealth App xChange portal. Partners include ArisGlobal, Medelinked, Vitrana, AiCure, and Parallel 6. Among the newest partners are mProve, Be the Partner, and DupCheck. They bring diverse capabilities including: patient recruitment; electronic informed consent; ePRO; source data capture; eTMF; electronic patient diaries; patient alerts and reminders; medication adherence; patient feedback tools; pharmacovigilance; duplicate enrollment checking; predictive analytics; and remote training. “Bioclinica is a pioneer,” says Jonathan Rabinowitz, founder and CEO of DupCheck, whose technology screens out duplicate subjects across sponsors and clinical trials globally, and can be integrated with Bioclinica’s Trident RTSM and Express EDC. “Bioclinica App xChange addresses the problem of disparate systems, and enables research organizations to leverage remarkable tools without adding site fatigue or burdening research organizations.” “As technology is evolving at such a rapid pace, we have a rigorous vetting process, as well as the connectivity and integration capability, to evaluate offerings and make them readily available to the industry,” Zielinski explains. “As heightened interest by potential partners wanting to become part of the Bioclinica eHealth platform coincides with growing interest by sponsors and CROs, everything is aligning for clinical researchers to reap the benefits of innovation for effective clinical development with increased efficiencies and reduced risk.” A number of partner technologies are available in the eHealth Cloud, addressing security, and compliance and validation requirements. Tapping Bioclinica for these technologies can streamline the contracting process, making one less vendor sponsors must manage. Bioclinica offers enabling professional and technology services to recognize the full value of its eHealth platform and help ensure successful implementation of partner applications, complete with hosting and help desk services. As for what is next, Zielinski says she and the eHealth Solutions team are continually evaluating potential partners from a value and integration standpoint, and are aggressively exploring new opportunities in areas such as eSource and site-focused solutions that can advance the 21st Century Cures Act. “Our aim is to bring added value to the research process, whether that’s tools used by the patient, site, sponsor or CRO, and to remain the leader in technology-enabled clinical trials with the most extensive eHealth platform.” Bioclinica will showcase App xChange partners at the European eHealth Conference on February 22-23. Visit the event site to learn more about App xChange and other Bioclinica solutions. To schedule an online or live App xChange demonstration, email Anne.Zielinski(at)Bioclinica(dot)com. Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. The eHealth Solutions segment comprises the eClinical Solutions platform; Financial Lifecycle Solutions; Safety and Regulatory Solutions; Strategic Consulting Services; App xChange Alliances; and eHealth Cloud Services. Under the Global Clinical Research segment, Bioclinica offers a network of research sites, patient recruitment services, and a post-approval research division. The Company serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia. Learn more at http://www.Bioclinica.com.
News Article | November 30, 2016
According to a new market report published by Persistence Market Research “Global Market Study on E-Clinical Solution Software: Asia to Witness Highest Growth by 2020”, the global e-clinical solution software market was valued at US$ 3,005 Mn in 2014 and is expected to expand at a CAGR of 13.8% from 2014 to 2020, to reach US$ 6,515.3 Mn by 2020. The global e-clinical solution software market is witnessing significant growth due to increasing clinical trials and R&D investments in pharmaceuticals and life science sectors. Increasing prevalence of diseases across the world is leading to rise in number of clinical trials. Various lifestyle-associated diseases and genetic disorders in the Middle East and North Africa have also led to increase in clinical trials in the respective regions. In addition, the pharmaceutical industry is facing immense pressure to reduce the time consumed to conduct clinical trials and increase effect of drugs. Presence of various end users such as pharmaceuticals, clinical research organizations (CROs), and healthcare providers has increased the demand for e-clinical solution software. The global e-clinical solution software market was valued at US$ 3,005 Mn in 2014 and is expected to expand at a CAGR of 13.8% from 2014 to 2020 to reach US$ 6,515.3 Mn by 2020. In North America, the average cost of research and development for a successful pharmaceutical drug continues to increase from pre-clinical stage i.e. initial development stage of drug till FDA approval i.e. launch of the drug in the market. According to Oracle Corporation – an e-clinical software company – the share of global clinical trials conducted in North America has reduced from 30% in 2006 to 19% in 2010. This was due to complex regulatory and legal frameworks in North America, which led to shifting of the clinical trials market to developing countries such as India and China. This may lead to sluggish growth of clinical trials in the region. Countries in Central and Eastern Europe provide abundant opportunities to life science companies for clinical development. According to Oracle Corporation – the percentage of clinical trials conducted in Western Europe has decreased from 25% to 19% and in Eastern Europe; the percentage has increased from 10% to 13% during 2006-2010. However, Asia has become one of the fastest-growing markets for pharmaceutical products. Improved industry regulatory laws and patent expiration laws in various countries such as Japan, China, and India, have led to the expansion of the clinical trials market in Asia. Cost of conducting clinical trials in Asia is lower compared to that in Europe and the U.S. Oracle Corporation, Medidata Solutions, PAREXEL International Corporation, BioClinica, and OmniComm Systems are some of the major players of e-clinical solution software market.
News Article | July 10, 2015
Research and Markets(http://www.researchandmarkets.com/research/g5h9sp/irt_market) has announced the addition of the "IRT Market Dynamics and Service Provider Benchmarking" report to their offering. This report benchmarks 26 IRT vendors (including in-house systems) across 20 different system attributes based on user experience. Anticipating that integration would be a challenge with eClinical technologies, ISR decided to take the unique approach of benchmarking IRT vendors' integration with 20 EDC vendors, 14 ePRO vendors, and 29 CTMS vendors. This provides a closer look into the eClinical space, focusing not only on use and selection but on integration as well. eClinical technology is an area of the clinical development market that this research industry expects will continue to grow while also consolidating. Many of the questions answered in this report offer projections regarding the utilization of IRT services as well as what sponsors would like to see improved as the IRT market moves forward. How you can use this report: The data and conclusions drawn in this report offer value to both sponsors and CROs that outsource IRT services as well as the vendors currently offering eClinical IRT solutions. Due to a large portion of this report focusing on the integration capabilities of IRT systems, this report also provides value to those companies with EDC, ePRO, and CTMS systems as a means of understanding which of these systems are being integrated most often with which IRT systems. Key Topics Covered: 1. Copyright and Usage Guidelines 2. Introduction 3. Report Benefits 4. Methodology and Sources 5. Executive Summary 6. Vendor Perception & Selection 7. Outsourcing Trends 8. Adaptive trial support 9. Trends in Integration 10. IRT Study Data 11. Vendor Attribute Performance and Integration Capabilities 12. Demographics Companies Mentioned - ARIS Global Gxchange IRT - Almac (IXRS, AXCESS, WEBEZ) - Avaya - BioClinica Trident - Cenduit - Criterium Telediary - EPharmaSolutions - Endpoint Pulse - Five9 IVR - ICON IcoPhone - In-House Developed IRT Systems - Medidata Balance - Merge Healthcare - IVR / IWR - Oracle Health Sciences IRT on Demand - PAREXEL Informatics Clinphone - PPD - Premier Research - S-Clinica - Suvoda IRT - Usan Voicenet - Veracity Logic - WCT Smart - Westat Westrax - inVentiv Health Clinical IRT For more information visit http://www.researchandmarkets.com/research/g5h9sp/irt_market
News Article | August 10, 2015
NEWTOWN, Pennsylvania, Aug. 10, 2015 /PRNewswire/ -- BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced the launch of the BioClinica eHealth Cloud™, a flexible and highly configurable platform offering that extends beyond the scope of traditional clinical trial technology approaches. The eHealth Cloud offers unlimited accessibility and a variety of delivery options to better meet the current and future needs of both preapproval and post approval research. With public consumer, private cloud, managed cloud, and custom options, the eHealth Cloud offers the right hosting subscription model to meet the specific needs of individual clinical trials. "The eHealth Cloud creates inherent flexibility, scalability and agility while maintaining the highest levels of quality and security," said Mukhtar Ahmed, BioClinica's President of eClinical Solutions. "This represents a major leap forward in clinical trial sponsor empowerment whereby sponsors and CROs' can choose from cloud delivery options that better enable them to achieve their scientific and business objectives." BioClinica's extensive and highly interoperable clinical trials platform, that includes Express EDC, Trident RTSM, Optimizer Supply Forecasting and Simulation, OnPoint CTMS and Compass "Intelligent" Risk-Based Monitoring solution, will be optimized for delivery through the eHealth Cloud. "The eHealth Cloud is an exciting new delivery model for BioClinica's eClinical suite of products, providing scale, reliability, and quality of service that measures up to the most complex clinical trials" said Andrew Masters, Senior Vice President of Product Development and Technology. Furthermore these powerful trial solutions will provide unprecedented integration capabilities though the BioClinica Cloud Transformation Gateway™, a secure standards-based integration exchange that connects BioClinica's eClinical Platform to innovative third party applications and industry data banks. "The BioClinica Cloud Transformation Gateway is a crucial part of the eHealth ecosystem," said Mr. Ahmed. "There are many talented and disruptive innovators across the healthcare spectrum developing niche applications that enhance patient engagement, point of care, and scientific analytical capabilities. Our open platform approach will enable us to seamlessly and rapidly connect our core clinical trial technologies and trusted clinical data repository to these industry innovators so that that sponsors, investigator sites, and patients can benefit from their use within the clinical research setting." Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica. BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. The company offers industry-leading medical imaging services, enterprise eClinical technologies, patient recruitment and retention, clinical research centers and cardiovascular safety solutions that bring quality and efficiency to every phase of clinical development. BioClinica's experience spans three decades and includes thousands of studies in all therapeutic areas. The company serves more than 400 pharmaceutical, biotechnology, and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia. For more information, please visit www.bioclinica.com.
News Article | July 10, 2015
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2vnmws/irt_market) has announced the addition of the "IRT Market Dynamics and Service Provider Benchmarking" report to their offering. This report benchmarks 26 IRT vendors (including in-house systems) across 20 different system attributes based on user experience. Anticipating that integration would be a challenge with eClinical technologies, ISR decided to take the unique approach of benchmarking IRT vendors' integration with 20 EDC vendors, 14 ePRO vendors, and 29 CTMS vendors. This provides a closer look into the eClinical space, focusing not only on use and selection but on integration as well. eClinical technology is an area of the clinical development market that this research industry expects will continue to grow while also consolidating. Many of the questions answered in this report offer projections regarding the utilization of IRT services as well as what sponsors would like to see improved as the IRT market moves forward. How you can use this report: The data and conclusions drawn in this report offer value to both sponsors and CROs that outsource IRT services as well as the vendors currently offering eClinical IRT solutions. Due to a large portion of this report focusing on the integration capabilities of IRT systems, this report also provides value to those companies with EDC, ePRO, and CTMS systems as a means of understanding which of these systems are being integrated most often with which IRT systems.
News Article | November 24, 2016
Revenue, means the sales value of eClinical Solutions This report studies eClinical Solutions in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Would like to place an order @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=762685 Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of eClinical Solutions in these regions, from 2011 to 2021 (forecast), like Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/762685-global-eclinical-solutions-market-research-report-2016 Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Split by application, this report focuses on consumption, market share and growth rate of eClinical Solutions in each application, can be divided into 1.2.1 Global Production Market Share of eClinical Solutions by Type in 2015 2.1 Global eClinical Solutions Production and Share by Manufacturers (2015 and 2016) 2.2 Global eClinical Solutions Revenue and Share by Manufacturers (2015 and 2016) 7.2.3 BioClinica, Inc. eClinical Solutions Production, Revenue, Price and Gross Margin (2015 and 2016) 7.5.3 DATATRAK International, Inc. eClinical Solutions Production, Revenue, Price and Gross Margin (2015 and 2016) 7.6.3 Medidata Solutions, Inc. eClinical Solutions Production, Revenue, Price and Gross Margin (2015 and 2016)